RITCH GO: Open Payments
NPI 1255843744 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 80 payments from 15 companies in 2025. Trend: 2023 $820 · 2024 $2,086 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $319 |
| AstraZeneca Pharmaceuticals LP | 8 | $226 |
| Novo Nordisk Inc | 11 | $202 |
| PFIZER INC. | 7 | $140 |
| Lilly USA, LLC | 9 | $134 |
| ABBVIE INC. | 6 | $120 |
| Dexcom, Inc. | 5 | $84 |
| Kowa Pharmaceuticals America, Inc. | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
Products named: TRELEGY ELLIPTA, BREZTRI, SHINGRIX, JARDIANCE, PREVNAR 20, Dexcom G6 Transmitter, ZORYVE, Wegovy.
Industry payments across NV — which companies pay providers there.
